-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Heterogeneity of CD19 CAR T Cells

Program: Scientific Symposia
Session: Cellular Heterogeneity and Relationship to Clinical Outcomes
Hematology Disease Topics & Pathways:
Research, Translational Research, Lymphomas, Non-Hodgkin lymphoma, B Cell lymphoma, Diseases, Aggressive lymphoma, Lymphoid Malignancies
Sunday, December 8, 2024, 4:30 PM-5:45 PM

Zinaida Good, PhD

Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA

Disclosures: Good: 10x Genomics: Research Funding; Kite, a Gilead Company: Research Funding; Mubadala Ventures: Consultancy; Boom Capital Ventures: Consultancy; Standard Biotools: Honoraria, Other: Travel Support; Sangamo Therapeutics: Honoraria.

See more of: Cellular Heterogeneity and Relationship to Clinical Outcomes
See more of: Scientific Symposia
Previous Presentation | Next Presentation >>